Pepke-Zaba J - Search Results

1

Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome.

Rhodes CJ, Otero-Núñez P, Wharton J, Swietlik EM, Kariotis S, Harbaum L, Dunning MJ, Elinoff JM, Errington N, Thompson AAR, Iremonger J, Coghlan JG, Corris PA, Howard LS, Kiely DG, Church C, Pepke-Zaba J, Toshner M, Wort SJ, Desai AA, Humbert M, Nichols WC, Southgate L, Trégouët DA, Trembath RC, Prokopenko I, Gräf S, Morrell NW, Wang D, Lawrie A, Wilkins MR. Rhodes CJ, et al. Am J Respir Crit Care Med. 2020 Aug 15;202(4):586-594. doi: 10.1164/rccm.202003-0510OC. Am J Respir Crit Care Med. 2020. PMID: 32352834 Free PMC article.

2

Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension.

Hoeper MM, Galié N, Murali S, Olschewski H, Rubenfire M, Robbins IM, Farber HW, McLaughlin V, Shapiro S, Pepke-Zaba J, Winkler J, Ewert R, Opitz C, Westerkamp V, Vachiéry JL, Torbicki A, Behr J, Barst RJ. Hoeper MM, et al. Am J Respir Crit Care Med. 2002 Feb 1;165(3):341-4. doi: 10.1164/ajrccm.165.3.200109-0130c. Am J Respir Crit Care Med. 2002. PMID: 11818318

3

Pulmonary hypertension in patients with COPD: NO treatment?

Pepke-Zaba J, Morrell NW. Pepke-Zaba J, et al. Thorax. 2003 Apr;58(4):283-4. doi: 10.1136/thorax.58.4.283. Thorax. 2003. PMID: 12668784 Free PMC article. No abstract available.

4

Interventional and surgical modalities of treatment for pulmonary arterial hypertension.

Klepetko W, Mayer E, Sandoval J, Trulock EP, Vachiery JL, Dartevelle P, Pepke-Zaba J, Jamieson SW, Lang I, Corris P. Klepetko W, et al. J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):73S-80S. doi: 10.1016/j.jacc.2004.02.039. J Am Coll Cardiol. 2004. PMID: 15194182 Free article. Review.

5

The endothelin system and its role in pulmonary arterial hypertension (PAH).

Pepke-Zaba J, Morrell NW. Pepke-Zaba J, et al. Thorax. 2005 Jun;60(6):443-4. doi: 10.1136/thx.2004.031724. Thorax. 2005. PMID: 15923241 Free PMC article. No abstract available.

6

Large granular lymphocyte leukaemia: a curable form of pulmonary arterial hypertension [corrected].

Howard LS, Chatterji S, Morrell NW, Pepke-Zaba J, Exley AR. Howard LS, et al. Hosp Med. 2005 Jun;66(6):364-5. doi: 10.12968/hmed.2005.66.6.18407. Hosp Med. 2005. PMID: 15974171 No abstract available.

7

The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study.

Hughes RJ, Jais X, Bonderman D, Suntharalingam J, Humbert M, Lang I, Simonneau G, Pepke-Zaba J. Hughes RJ, et al. Eur Respir J. 2006 Jul;28(1):138-43. doi: 10.1183/09031936.06.00135905. Epub 2006 Apr 12. Eur Respir J. 2006. PMID: 16611652 Free article.

8

Current understanding of the role of bosentan in inoperable chronic thromboembolic pulmonary hypertension.

Hughes R, Jais X, Suntharalingam J, Humbert M, Parent F, Simonneau G, Pepke-Zaba J. Hughes R, et al. Expert Opin Pharmacother. 2006 Jun;7(9):1133-8. doi: 10.1517/14656566.7.9.1133. Expert Opin Pharmacother. 2006. PMID: 16732700 Review.

9

Effects of nebulised iloprost on pulmonary function and gas exchange in severe pulmonary hypertension.

Reichenberger F, Mainwood A, Doughty N, Fineberg A, Morrell NW, Pepke-Zaba J. Reichenberger F, et al. Respir Med. 2007 Feb;101(2):217-22. doi: 10.1016/j.rmed.2006.05.019. Epub 2006 Jul 10. Respir Med. 2007. PMID: 16831539 Free article.

10

Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm.

Bresser P, Pepke-Zaba J, Jaïs X, Humbert M, Hoeper MM. Bresser P, et al. Proc Am Thorac Soc. 2006 Sep;3(7):594-600. doi: 10.1513/pats.200605-115LR. Proc Am Thorac Soc. 2006. PMID: 16963540 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters